The University of Chicago Header Logo

Connection

J. Thistlethwaite to Humans

This is a "connection" page, showing publications J. Thistlethwaite has written about Humans.
Connection Strength

0.688
  1. Gender and race/ethnicity differences in living kidney donor demographics: Preference or disparity? Transplant Rev (Orlando). 2021 07; 35(3):100614.
    View in: PubMed
    Score: 0.025
  2. Living Donation by Individuals with Life-Limiting Conditions. J Law Med Ethics. 2019 03; 47(1):112-122.
    View in: PubMed
    Score: 0.021
  3. Developing an ethics framework for living donor transplantation. J Med Ethics. 2018 12; 44(12):843-850.
    View in: PubMed
    Score: 0.020
  4. Introducing Genetic Tests With Uncertain Implications in Living Donor Kidney Transplantation: ApoL1 as a Case Study. Prog Transplant. 2016 Sep; 26(3):203-6.
    View in: PubMed
    Score: 0.018
  5. The 1966 Ciba Symposium on Transplantation Ethics: 50 Years Later. Transplantation. 2016 Jun; 100(6):1191-7.
    View in: PubMed
    Score: 0.018
  6. Patient portals: furthering the reality of patient partnership. Aust Fam Physician. 2015 Jul; 44(7):524-5.
    View in: PubMed
    Score: 0.016
  7. Racial disparities in reaching the renal transplant waitlist: is geography as important as race? Clin Transplant. 2015 Jun; 29(6):531-8.
    View in: PubMed
    Score: 0.016
  8. Outcomes after kidney donation. JAMA. 2014 Jul 02; 312(1):94.
    View in: PubMed
    Score: 0.015
  9. A review of longitudinal community and hospital placements in medical education: BEME Guide No. 26. Med Teach. 2013 Aug; 35(8):e1340-64.
    View in: PubMed
    Score: 0.014
  10. Age should not be considered in the allocation of deceased donor kidneys. Semin Dial. 2012 Nov-Dec; 25(6):675-81.
    View in: PubMed
    Score: 0.014
  11. Equal Opportunity Supplemented by Fair Innings: equity and efficiency in allocating deceased donor kidneys. Am J Transplant. 2012 Aug; 12(8):2115-24.
    View in: PubMed
    Score: 0.013
  12. Different standards are not double standards: all elective surgical patients are not alike. J Clin Ethics. 2012; 23(2):118-28.
    View in: PubMed
    Score: 0.013
  13. Transforming health professionals' education. Lancet. 2011 Apr 09; 377(9773):1236; author reply 1238-9.
    View in: PubMed
    Score: 0.012
  14. Medical student burnout and professionalism. JAMA. 2011 Jan 05; 305(1):37-8; author reply 38.
    View in: PubMed
    Score: 0.012
  15. Long-term consequences of kidney donation. N Engl J Med. 2009 May 28; 360(22):2371; author reply 2372.
    View in: PubMed
    Score: 0.011
  16. Potential inefficiency of a proposed efficiency model for kidney allocation. Am J Kidney Dis. 2008 Apr; 51(4):545-8.
    View in: PubMed
    Score: 0.010
  17. We need a registry of living kidney donors. Hastings Cent Rep. 2007 Nov-Dec; 37(6):1 p following 48.
    View in: PubMed
    Score: 0.010
  18. Shared decision making between registrars and patients--web based decision aids. Aust Fam Physician. 2007 Aug; 36(8):670-2.
    View in: PubMed
    Score: 0.009
  19. Shared decision making in deceased-donor transplantation. Lancet. 2006 Jul 22; 368(9532):333-7.
    View in: PubMed
    Score: 0.009
  20. Shared decision making and decision aids - a literature review. Aust Fam Physician. 2006 Jul; 35(7):537-40.
    View in: PubMed
    Score: 0.009
  21. Full engagement in health: shared decision making requires education. BMJ. 2005 Jan 29; 330(7485):255.
    View in: PubMed
    Score: 0.008
  22. Medical students' attitudes towards concordance in medicine taking: exploring the impact of an educational intervention. Educ Health (Abingdon). 2003 Nov; 16(3):307-17.
    View in: PubMed
    Score: 0.007
  23. Should all living donors be treated equally? Transplantation. 2002 Aug 15; 74(3):418-21; discussion 421-2.
    View in: PubMed
    Score: 0.007
  24. Making and sharing decisions about management with patients: the views and experiences of pre-registration house officers in general practice and hospital. Med Educ. 2002 Jan; 36(1):49-55.
    View in: PubMed
    Score: 0.006
  25. Kidney transplantation: graft monitoring and immunosuppression. World J Surg. 2002 Feb; 26(2):185-93.
    View in: PubMed
    Score: 0.006
  26. Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group. Transplantation. 2000 Sep 15; 70(5):784-90.
    View in: PubMed
    Score: 0.006
  27. Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival. Transplantation. 2000 Mar 15; 69(5):904-9.
    View in: PubMed
    Score: 0.006
  28. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation. 1999 Sep 15; 68(5):608-16.
    View in: PubMed
    Score: 0.005
  29. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. Am J Kidney Dis. 1999 Jul; 34(1):69-84.
    View in: PubMed
    Score: 0.005
  30. Liver transplantation in the first three months of life. Transplantation. 1998 Sep 15; 66(5):606-9.
    View in: PubMed
    Score: 0.005
  31. Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience. Transplant Proc. 1998 Jun; 30(4):1369-70.
    View in: PubMed
    Score: 0.005
  32. Successful use of tacrolimus for initial rejection episodes after liver transplantation. Transplant Proc. 1998 Jun; 30(4):1407-8.
    View in: PubMed
    Score: 0.005
  33. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Jun; 30(4):1538-40.
    View in: PubMed
    Score: 0.005
  34. An analysis of hepatic retransplantation in children. Transplantation. 1998 May 15; 65(9):1172-8.
    View in: PubMed
    Score: 0.005
  35. Ethical Analysis and Policy Recommendations Regarding Domino Liver Transplantation. Transplantation. 2018 05; 102(5):803-808.
    View in: PubMed
    Score: 0.005
  36. Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases. Transplant Proc. 1998 Mar; 30(2):270-1.
    View in: PubMed
    Score: 0.005
  37. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Mar; 30(2):507-8.
    View in: PubMed
    Score: 0.005
  38. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation. 1998 Feb 15; 65(3):439-42.
    View in: PubMed
    Score: 0.005
  39. Reversal of accelerated renal allograft rejection with FK 506. Clin Transplant. 1997 Aug; 11(4):251-4.
    View in: PubMed
    Score: 0.005
  40. Transplantation. JAMA. 1997 Jun 18; 277(23):1902-4.
    View in: PubMed
    Score: 0.005
  41. Retransplantation for failed hepatic allografts in children. Transplant Proc. 1997 Feb-Mar; 29(1-2):442-3.
    View in: PubMed
    Score: 0.005
  42. Impact of a liberalized donor acceptance policy on liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):484.
    View in: PubMed
    Score: 0.005
  43. Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy. Transplant Proc. 1997 Feb-Mar; 29(1-2):1549.
    View in: PubMed
    Score: 0.005
  44. Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor. Transplantation. 1996 Nov 27; 62(10):1516-9.
    View in: PubMed
    Score: 0.005
  45. Comparison of pancreas transplantation with portal venous and enteric exocrine drainage to the standard technique utilizing bladder drainage of exocrine secretions. Transplantation. 1996 Nov 15; 62(9):1353-6.
    View in: PubMed
    Score: 0.005
  46. Kidney Donor Profile Index Does Not Accurately Predict the Graft Survival of Pediatric Deceased Donor Kidneys. Transplantation. 2016 Nov; 100(11):2471-2478.
    View in: PubMed
    Score: 0.005
  47. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Transplantation. 1996 Oct 15; 62(7):906-10.
    View in: PubMed
    Score: 0.004
  48. Attitudes of Lay Stakeholders and Transplant Professionals About Disclosure to Living Kidney Donors in Exchanges and Chains. Prog Transplant. 2016 Dec; 26(4):299-308.
    View in: PubMed
    Score: 0.004
  49. Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation. 1996 Aug 27; 62(4):451-6.
    View in: PubMed
    Score: 0.004
  50. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation. 1996 Aug 15; 62(3):370-5.
    View in: PubMed
    Score: 0.004
  51. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation. Transplant Proc. 1996 Aug; 28(4):2136-7.
    View in: PubMed
    Score: 0.004
  52. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
    View in: PubMed
    Score: 0.004
  53. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection. Clin Transplant. 1996 Aug; 10(4):389-95.
    View in: PubMed
    Score: 0.004
  54. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Transplantation. 1996 May 15; 61(9):1365-9.
    View in: PubMed
    Score: 0.004
  55. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. Transplant Proc. 1996 Apr; 28(2):1014.
    View in: PubMed
    Score: 0.004
  56. Pancreas transplantation with portal venous drainage and enteric exocrine drainage offers early advantages without compromising safety or allograft function. Transplant Proc. 1995 Dec; 27(6):3002-3.
    View in: PubMed
    Score: 0.004
  57. Late complications in kidney-pancreas transplant recipients. Transplant Proc. 1995 Dec; 27(6):3118.
    View in: PubMed
    Score: 0.004
  58. To tell or not to tell: attitudes of transplant surgeons and transplant nephrologists regarding the disclosure of recipient information to living kidney donors. Clin Transplant. 2015 Dec; 29(12):1203-12.
    View in: PubMed
    Score: 0.004
  59. Age and equity in liver transplantation: An organ allocation model. Liver Transpl. 2015 Oct; 21(10):1241-9.
    View in: PubMed
    Score: 0.004
  60. Disclosing Health and Health Behavior Information between Living Donors and Their Recipients. Clin J Am Soc Nephrol. 2015 Sep 04; 10(9):1609-16.
    View in: PubMed
    Score: 0.004
  61. Immunomodulation of human islets results in prolonged in vivo islet graft survival. Transplant Proc. 1995 Feb; 27(1):611-2.
    View in: PubMed
    Score: 0.004
  62. Changes in urinary cytokine mRNA profile after successful therapy for acute cellular renal allograft rejection. Transplant Proc. 1995 Feb; 27(1):887-9.
    View in: PubMed
    Score: 0.004
  63. Liver transplantation at the University of Chicago. Clin Transpl. 1995; 187-97.
    View in: PubMed
    Score: 0.004
  64. The recurrence of recurrent membranous glomerulopathy in a renal transplant recipient: case report and literature review. Am J Kidney Dis. 1994 Nov; 24(5):873-8.
    View in: PubMed
    Score: 0.004
  65. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J Immunol. 1994 Sep 15; 153(6):2738-49.
    View in: PubMed
    Score: 0.004
  66. Primum non nocere: shared informed decision making in low back pain--a pilot cluster randomised trial. BMC Musculoskelet Disord. 2014 Aug 21; 15:282.
    View in: PubMed
    Score: 0.004
  67. Decision making in liver transplantation--limited application of the liver donor risk index. Liver Transpl. 2014 Jul; 20(7):831-7.
    View in: PubMed
    Score: 0.004
  68. The correlation between donor characteristics and the success of human islet isolation. Transplantation. 1994 Mar 27; 57(6):954-8.
    View in: PubMed
    Score: 0.004
  69. Living related liver transplantation in children: a report of the first 58 recipients at the University of Chicago. Transpl Int. 1994; 7 Suppl 1:S111-3.
    View in: PubMed
    Score: 0.004
  70. When the living and the deceased cannot agree on organ donation: a survey of US organ procurement organizations (OPOs). Am J Transplant. 2014 Jan; 14(1):172-7.
    View in: PubMed
    Score: 0.004
  71. Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1. Lancet. 1993 Sep 25; 342(8874):779-80.
    View in: PubMed
    Score: 0.004
  72. A K-nearest neighbors survival probability prediction method. Stat Med. 2013 May 30; 32(12):2062-9.
    View in: PubMed
    Score: 0.004
  73. General aspects of cytokine-release syndrome: timing and incidence of symptoms. Transplant Proc. 1993 Apr; 25(2 Suppl 1):16-20.
    View in: PubMed
    Score: 0.004
  74. OKT3 induction in pediatric renal transplantation. Pediatr Nephrol. 1993 Feb; 7(1):45-9.
    View in: PubMed
    Score: 0.003
  75. Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation. Diabetes. 1992 Oct; 41(10):1346-54.
    View in: PubMed
    Score: 0.003
  76. Pediatric liver transplantation at the University of Chicago Hospitals. Clin Transpl. 1992; 179-89.
    View in: PubMed
    Score: 0.003
  77. Innovative use of organs for liver transplantation. Transplant Proc. 1991 Aug; 23(4):2147-51.
    View in: PubMed
    Score: 0.003
  78. Risk, prognosis, and unintended consequences in kidney allocation. N Engl J Med. 2011 Apr 07; 364(14):1285-7.
    View in: PubMed
    Score: 0.003
  79. Study protocol: improving patient choice in treating low back pain (IMPACT-LBP): a randomised controlled trial of a decision support package for use in physical therapy. BMC Musculoskelet Disord. 2011 Feb 25; 12:52.
    View in: PubMed
    Score: 0.003
  80. What are the perceived learning needs of Australian general practice registrars for quality prescribing? BMC Med Educ. 2010 Dec 09; 10:92.
    View in: PubMed
    Score: 0.003
  81. Increased utilization of organ donors: transplantation of two recipients from single donor livers. Transplant Proc. 1990 Aug; 22(4):1485-6.
    View in: PubMed
    Score: 0.003
  82. The use of the T-cell flow cytometry crossmatch to evaluate the significance of positive B-cell serologic crossmatches in cadaveric donor renal transplantation. Transplant Proc. 1990 Aug; 22(4):1897-8.
    View in: PubMed
    Score: 0.003
  83. Changing attitudes toward influenza vaccination in U.S. Kidney transplant programs over the past decade. Clin J Am Soc Nephrol. 2010 Sep; 5(9):1637-41.
    View in: PubMed
    Score: 0.003
  84. Selective OKT3 induction therapy in adult cadaveric-donor renal transplant recipients. Am J Kidney Dis. 1989 Nov; 14(5 Suppl 2):28-34.
    View in: PubMed
    Score: 0.003
  85. Percapsular and percutaneous embolization of renal transplant pseudoaneurysm and AV fistula: case report. Cardiovasc Intervent Radiol. 1989 Sep-Oct; 12(5):270-3.
    View in: PubMed
    Score: 0.003
  86. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction. Transplant Proc. 1989 Feb; 21(1 Pt 2):1890-2.
    View in: PubMed
    Score: 0.003
  87. Procurement of both liver and whole pancreas/duodenum allografts from a single donor without the use of interposition vascular grafts on transplantation. Transplant Proc. 1988 Oct; 20(5):833-4.
    View in: PubMed
    Score: 0.003
  88. Minors as living solid-organ donors. Pediatrics. 2008 Aug; 122(2):454-61.
    View in: PubMed
    Score: 0.003
  89. Pelvic examination of asymptomatic women - attitudes and clinical practice. Aust Fam Physician. 2008 Jun; 37(6):493-6.
    View in: PubMed
    Score: 0.003
  90. An empirical investigation of physicians' attitudes toward intrasibling kidney donation by minor twins. Transplantation. 2008 May 15; 85(9):1235-9.
    View in: PubMed
    Score: 0.003
  91. Complications and monitoring of OKT3 therapy. Am J Kidney Dis. 1988 Feb; 11(2):112-9.
    View in: PubMed
    Score: 0.002
  92. Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection. Am J Kidney Dis. 1988 Feb; 11(2):94-8.
    View in: PubMed
    Score: 0.002
  93. T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 1):722-4.
    View in: PubMed
    Score: 0.002
  94. The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine. Transplant Proc. 1987 Feb; 19(1 Pt 3):1901-4.
    View in: PubMed
    Score: 0.002
  95. OKT3 treatment of steroid-resistant renal allograft rejection. Transplantation. 1987 Feb; 43(2):176-84.
    View in: PubMed
    Score: 0.002
  96. Omega jejunoduodenal anastomosis for pancreas transplant. J Am Coll Surg. 2006 Jun; 202(6):1021-4.
    View in: PubMed
    Score: 0.002
  97. Attitudes of minority patients with end-stage renal disease regarding ABO-incompatible list-paired exchanges. Am J Transplant. 2006 Jan; 6(1):83-8.
    View in: PubMed
    Score: 0.002
  98. Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation. Hum Immunol. 1985 Nov; 14(3):314-23.
    View in: PubMed
    Score: 0.002
  99. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation. 2005 Jan 27; 79(2):228-35.
    View in: PubMed
    Score: 0.002
  100. Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. Transplantation. 2004 Oct 27; 78(8):1233-6.
    View in: PubMed
    Score: 0.002
  101. Platelets and capillary injury in acute humoral rejection of renal allografts. Hum Pathol. 2003 Jun; 34(6):533-40.
    View in: PubMed
    Score: 0.002
  102. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation. 2002 Apr 15; 73(7):1166-9.
    View in: PubMed
    Score: 0.002
  103. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol. 2001 Feb; 32(2):205-15.
    View in: PubMed
    Score: 0.002
  104. Transplantation and the CD28/CTLA4/B7 pathway. Transplant Proc. 2001 Feb-Mar; 33(1-2):209-11.
    View in: PubMed
    Score: 0.002
  105. Combined liver and kidney transplantation in children. Transplantation. 2000 Jul 15; 70(1):100-5.
    View in: PubMed
    Score: 0.001
  106. Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients. Ann Surg. 2000 Jul; 232(1):104-11.
    View in: PubMed
    Score: 0.001
  107. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. Transplantation. 1999 Oct 27; 68(8):1117-24.
    View in: PubMed
    Score: 0.001
  108. Drug-induced acute interstitial nephritis in renal allografts: histopathologic features and clinical course in six patients. Am J Kidney Dis. 1999 Sep; 34(3):540-8.
    View in: PubMed
    Score: 0.001
  109. Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis). Transplantation. 1999 Aug 15; 68(3):331-7.
    View in: PubMed
    Score: 0.001
  110. The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol. 1999 Aug; 10(8):1806-14.
    View in: PubMed
    Score: 0.001
  111. Imaging of pancreatic transplantation using portal venous and enteric exocrine drainage. AJR Am J Roentgenol. 1998 Jul; 171(1):157-63.
    View in: PubMed
    Score: 0.001
  112. Pathogenesis of early operative site infections after orthotopic liver transplantation. Transplantation. 1998 Jun 15; 65(11):1500-3.
    View in: PubMed
    Score: 0.001
  113. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. Transplant Proc. 1998 Jun; 30(4):1234-5.
    View in: PubMed
    Score: 0.001
  114. Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. Transplant Proc. 1998 Jun; 30(4):1378-9.
    View in: PubMed
    Score: 0.001
  115. Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients. Transplant Proc. 1998 Jun; 30(4):1435-6.
    View in: PubMed
    Score: 0.001
  116. Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol. 1998 Apr; 9(4):677-83.
    View in: PubMed
    Score: 0.001
  117. Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation. 1998 Feb 15; 65(3):393-6.
    View in: PubMed
    Score: 0.001
  118. Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. Transplantation. 1997 Jul 27; 64(2):258-63.
    View in: PubMed
    Score: 0.001
  119. Bone allografts are immunogenic and may preclude subsequent organ transplants. Clin Orthop Relat Res. 1997 Jul; (340):215-9.
    View in: PubMed
    Score: 0.001
  120. Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children. J Pediatr. 1997 Jul; 131(1 Pt 1):98-104.
    View in: PubMed
    Score: 0.001
  121. Ethics of a paired-kidney-exchange program. N Engl J Med. 1997 Jun 12; 336(24):1752-5.
    View in: PubMed
    Score: 0.001
  122. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. Transplant Proc. 1997 Feb-Mar; 29(1-2):307.
    View in: PubMed
    Score: 0.001
  123. Biliary complications in living donor liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):419-20.
    View in: PubMed
    Score: 0.001
  124. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group. Transplant Proc. 1996 Dec; 28(6):3163-4.
    View in: PubMed
    Score: 0.001
  125. Use of polytetrafluoroethylene patch for temporary wound closure after pediatric liver transplantation. Transplantation. 1996 Oct 15; 62(7):1034-6.
    View in: PubMed
    Score: 0.001
  126. Portal vein thrombosis and stenosis in pediatric liver transplantation. Transplantation. 1996 Sep 27; 62(6):748-54.
    View in: PubMed
    Score: 0.001
  127. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation. 1996 Sep 15; 62(5):594-9.
    View in: PubMed
    Score: 0.001
  128. Angiographic selection criteria for living related liver transplant donors. AJR Am J Roentgenol. 1996 May; 166(5):1103-8.
    View in: PubMed
    Score: 0.001
  129. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. Transplant Proc. 1996 Apr; 28(2):998-9.
    View in: PubMed
    Score: 0.001
  130. OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival. Kidney Int. 1996 Mar; 49(3):768-72.
    View in: PubMed
    Score: 0.001
  131. Allograft rejection in pediatric recipients of living related liver transplants. Hepatology. 1996 Jan; 23(1):40-3.
    View in: PubMed
    Score: 0.001
  132. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med. 1995 Jul 01; 123(1):18-26.
    View in: PubMed
    Score: 0.001
  133. Inhibition of T-cell activation by an anti-human class I MHC reactive monoclonal antibody occurs at a point distal to TCR-CD3 mediated signal transduction. Transplant Proc. 1995 Feb; 27(1):395-7.
    View in: PubMed
    Score: 0.001
  134. OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies. Transplant Proc. 1995 Feb; 27(1):852-3.
    View in: PubMed
    Score: 0.001
  135. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies. Transplantation. 1994 Sep 27; 58(6):681-9.
    View in: PubMed
    Score: 0.001
  136. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules. J Immunol. 1994 Aug 01; 153(3):1054-67.
    View in: PubMed
    Score: 0.001
  137. A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation. 1994 Jun 15; 57(11):1537-43.
    View in: PubMed
    Score: 0.001
  138. Prolongation of human pancreatic islet xenografts by pretreatment of islets with anti-human ICAM-1 monoclonal antibody. Transplant Proc. 1994 Jun; 26(3):1120.
    View in: PubMed
    Score: 0.001
  139. Oscillatory insulin secretion after pancreas transplant. Diabetes. 1993 Jun; 42(6):855-61.
    View in: PubMed
    Score: 0.001
  140. Immunosuppressive effects of anti-CD3 MAb and soluble co-stimulatory molecules. Transplant Proc. 1993 Feb; 25(1 Pt 1):546-7.
    View in: PubMed
    Score: 0.001
  141. Use of cryopreserved vein allogeneic homografts in liver transplantation. Transplant Proc. 1993 Feb; 25(1 Pt 2):1091-2.
    View in: PubMed
    Score: 0.001
  142. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation. Transplantation. 1993 Jan; 55(1):44-50.
    View in: PubMed
    Score: 0.001
  143. Abdominal pain in a young girl due to congenital stenosis of the common bile duct with mucus plug formation. J Pediatr Gastroenterol Nutr. 1992 Nov; 15(4):440-3.
    View in: PubMed
    Score: 0.001
  144. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science. 1992 Aug 07; 257(5071):789-92.
    View in: PubMed
    Score: 0.001
  145. Patterns of infection after pediatric liver transplantation. Am J Dis Child. 1992 Aug; 146(8):924-9.
    View in: PubMed
    Score: 0.001
  146. Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody. J Immunol. 1992 Jun 01; 148(11):3461-8.
    View in: PubMed
    Score: 0.001
  147. Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression. J Immunol. 1992 May 01; 148(9):2756-63.
    View in: PubMed
    Score: 0.001
  148. Biliary complications in pediatric liver transplantation. A comparison of reduced-size and whole grafts. Transplantation. 1992 Feb; 53(2):391-5.
    View in: PubMed
    Score: 0.001
  149. Hepatic artery thrombosis in infants. A comparison of whole livers, reduced-size grafts, and grafts from living-related donors. Transplantation. 1992 Feb; 53(2):396-9.
    View in: PubMed
    Score: 0.001
  150. Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg. 1991 Oct; 214(4):428-37; discussion 437-9.
    View in: PubMed
    Score: 0.001
  151. Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies. Transplantation. 1991 Aug; 52(2):361-8.
    View in: PubMed
    Score: 0.001
  152. OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release. Transplantation. 1991 Aug; 52(2):354-60.
    View in: PubMed
    Score: 0.001
  153. [Splitting liver transplantation. Orthotopic liver transplantation in two recipients with a single donor liver]. Helv Chir Acta. 1991 Jul; 58(1-2):147-8.
    View in: PubMed
    Score: 0.001
  154. [Preservation of donor livers with University of Wisconsin solution]. Helv Chir Acta. 1991 Jul; 58(1-2):159-61.
    View in: PubMed
    Score: 0.001
  155. OKT3 therapy for hepatic allograft rejection. Differential response in adults and children. Transplantation. 1991 Jun; 51(6):1207-12.
    View in: PubMed
    Score: 0.001
  156. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis. 1991 May-Jun; 13(3):387-96.
    View in: PubMed
    Score: 0.001
  157. Indications for liver transplantation in pediatric patients. Clin Transplant. 1991 Apr; 5(2 part 2):155-60.
    View in: PubMed
    Score: 0.001
  158. T-cell activation and lymphokine production induced by antihuman CD3 monoclonal antibodies. Transplant Proc. 1991 Feb; 23(1 Pt 1):81-2.
    View in: PubMed
    Score: 0.001
  159. Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients. Am J Nephrol. 1991; 11(6):470-4.
    View in: PubMed
    Score: 0.001
  160. T lymphocyte activation following OKT3 treatment. Curr Surg. 1990 Nov-Dec; 47(6):458-9.
    View in: PubMed
    Score: 0.001
  161. Activation of human T cells in vivo following treatment of transplant recipients with OKT3. Transplantation. 1990 Oct; 50(4):608-12.
    View in: PubMed
    Score: 0.001
  162. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg. 1990 Sep; 212(3):368-75; discussion 375-7.
    View in: PubMed
    Score: 0.001
  163. OKT3 therapy for hepatic allograft rejection: comparison of results in adults and children. Transplant Proc. 1990 Aug; 22(4):1765-6.
    View in: PubMed
    Score: 0.001
  164. Transplantation of two patients with one liver. Analysis of a preliminary experience with 'split-liver' grafting. Ann Surg. 1990 Jul; 212(1):14-22.
    View in: PubMed
    Score: 0.001
  165. The ethical assessment of innovative therapies: liver transplantation using living donors. Theor Med. 1990 Jun; 11(2):87-94.
    View in: PubMed
    Score: 0.001
  166. Successful hepatic transplantation in congenital absence of recipient portal vein. Surgery. 1990 Apr; 107(4):475-9.
    View in: PubMed
    Score: 0.001
  167. Choledochocholedochostomy without a T tube or internal stent in transplantation of the liver. Surg Gynecol Obstet. 1990 Mar; 170(3):239-44.
    View in: PubMed
    Score: 0.001
  168. Experience with radical resection in the management of proximal bile duct cancer. HPB Surg. 1989 Nov; 1(4):297-305; discussion 305-7.
    View in: PubMed
    Score: 0.001
  169. Reduced-size orthotopic liver transplantation: use in the management of children with chronic liver disease. Hepatology. 1989 Nov; 10(5):867-72.
    View in: PubMed
    Score: 0.001
  170. Ethics of liver transplantation with living donors. N Engl J Med. 1989 Aug 31; 321(9):620-2.
    View in: PubMed
    Score: 0.001
  171. Right heart dysfunction, pulmonary embolism, and paradoxical embolization during liver transplantation. A transesophageal two-dimensional echocardiographic study. Anesth Analg. 1989 Jun; 68(6):777-82.
    View in: PubMed
    Score: 0.001
  172. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function. Transplant Proc. 1989 Feb; 21(1 Pt 2):1641-2.
    View in: PubMed
    Score: 0.001
  173. [Shunt surgery with reference to indications for liver transplantation]. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1989; 293-9.
    View in: PubMed
    Score: 0.001
  174. Effect of massive transfusion during liver transplantation on rejection and infection. Transplant Proc. 1988 Dec; 20(6):1135-7.
    View in: PubMed
    Score: 0.001
  175. Liver transplantation, including the concept of reduced-size liver transplants in children. Ann Surg. 1988 Oct; 208(4):410-20.
    View in: PubMed
    Score: 0.001
  176. Improved results of preservation of hepatic grafts preflushed with albumin and prostaglandins. Transplant Proc. 1988 Oct; 20(5):992-3.
    View in: PubMed
    Score: 0.001
  177. Pediatric orthotopic liver transplantation: multifactorial predictions of blood loss. Anesthesiology. 1988 Apr; 68(4):607-11.
    View in: PubMed
    Score: 0.001
  178. Liver transplantation with reduced-size donor organs. Transplantation. 1988 Mar; 45(3):519-24.
    View in: PubMed
    Score: 0.001
  179. Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease. J Infect Dis. 1988 Feb; 157(2):383-5.
    View in: PubMed
    Score: 0.001
  180. Reexposure to OKT3 in renal allograft recipients. Transplantation. 1988 Feb; 45(2):349-53.
    View in: PubMed
    Score: 0.001
  181. Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts. Am Surg. 1987 Jul; 53(7):407-9.
    View in: PubMed
    Score: 0.001
  182. [Heterotopic or orthotopic liver replacement with liver segments?]. Z Gastroenterol Verh. 1987 Apr; 22:66-72.
    View in: PubMed
    Score: 0.001
  183. An immunosuppressive protocol compatible with the United States kidney transplant diagnosis related grouping. Transplant Proc. 1987 Feb; 19(1 Pt 3):1959-60.
    View in: PubMed
    Score: 0.001
  184. Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors. Transplant Proc. 1987 Feb; 19(1 Pt 3):1915-6.
    View in: PubMed
    Score: 0.001
  185. ANEURYSM OF THE CELIAC ARTERY: CASE REPORT OF SUCCESSFUL MANAGEMENT. Ann Surg. 1965 Jan; 161:83-5.
    View in: PubMed
    Score: 0.000
  186. Effect of class II antigen matching on renal allograft survival in miniature swine. J Exp Med. 1984 Nov 01; 160(5):1495-508.
    View in: PubMed
    Score: 0.000
  187. Fistula cancer. Ann Surg. 1959 Jun; 149(6):815-20; discussion 821.
    View in: PubMed
    Score: 0.000
  188. Observations on fluctuations in blood volume as determined with radioactive isotopes. Anesth Analg. 1957 Sep-Oct; 36(5):54-60.
    View in: PubMed
    Score: 0.000
  189. Blood volume fluctuations determined by radioisotopes of chromium and radioactive iodinated serum albumin. Surg Gynecol Obstet. 1957 Jul; 105(1):34-8.
    View in: PubMed
    Score: 0.000
  190. The effect of banthine, vagotomy, and subtotal gastrectomy upon pancreatic secretion. Surg Gynecol Obstet. 1951 Nov; 93(5):616-20.
    View in: PubMed
    Score: 0.000
  191. Cholecystitis and cholelithiasis in young women following pregnancy. Surgery. 1950 Dec; 28(6):983-96.
    View in: PubMed
    Score: 0.000
  192. The nutrition of blood vessel grafts. An India ink injection study of their vascularization. Surg Gynecol Obstet. 1952 Mar; 94(3):311-6.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.